Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Jul 17, 2025 | Rewey Asset Management | 6.1% | -1.3% | DCO, HOLX, LAKE, OFIX | active, defense, Medical Devices, small caps, SMID, undervalued, value | Manager believes small and SMID caps remain neglected and undervalued with many names fitting criteria for long-term selection. Active stock selection is appropriate for smaller caps due to limited liquidity in ETFs, ability to avoid weaker companies, and vast under-researched universe with over 5000 equities providing alpha generation opportunities. | OFIX LAKE DCO OFIX LAKE DCO |
View |
| 2026 Q2 | Jul 16, 2026 | Rewey Asset Management | 20.1% | 31.2% | CCRN, OFIX, UCTT, VNT, WBS | Capital markets, defense, industrials, Regional Banks, semiconductors, Small Cap Rotation, SMID Cap, value | VNT OFIX UCTT |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | Fund Letters | Rewey Asset Management | Orthofix Medical Inc. | Medical Devices | Health Care Equipment | Bull | NASDAQ | Bone Growth Stimulation, healthcare, Medical devices, Orthopedic Equipment, Regulatory, Reimbursement, turnaround, Value | View Pitch |
| Apr 13, 2026 | Fund Letters | Rewey Asset Management | Orthofix Medical | Health Care | Health Care Equipment | Bull | NASDAQ | 7D FLASH, AccelStim, Bone Growth Therapy, Diabetic Amputation, Engine Capital, FDA clearance, Innovation Pipeline, insider buying, margin expansion, Medical devices, Orthopedics, Seaspine Merger, Spine | View Pitch |
| Jan 8, 2026 | Fund Letters | Chip Rewey | Orthofix Medical Inc. | Health Care | Medical Devices | Bull | NASDAQ | Activism, Insiderbuying, Marginexpansion, Medtech, turnaround | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| Paul Tudor Jones | Tudor Investment Corp | $53.4B | $3.1M | 0.01% | 202,606 | -231,482 | -53.33% | 0.5637% |
| Steven A. Cohen | Point72 Asset Management | $86.8B | $1.3M | 0.00% | 88,216 | +88,216 | +100.00% | 0.2454% |
| Cliff Asness | AQR Capital Management | $190.6B | $1.3M | 0.00% | 86,708 | +53,144 | +158.34% | 0.2412% |
| Dmitry Balyasny | Balyasny Asset Management | $76.6B | $238,391 | 0.00% | 15,725 | +15,725 | +100.00% | 0.0438% |
| Israel Englander | Millennium Management LLC | $233.2B | $21.8M | 0.01% | 1,441,267 | -34,451 | -2.33% | 4.0099% |
| Mario Gabelli | GAMCO Investors | $10.4B | $2.6M | 0.03% | 171,800 | +5,800 | +3.49% | 0.4780% |
| Kevin M. Keeley | Keeley-Teton Advisors, LLC | $824.8M | $1.4M | 0.17% | 83,657 | +22,320 | +36.39% | 0.2504% |